Elevance Health, Inc. (NYSE:ELV) Shares Acquired by APG Asset Management N.V.

APG Asset Management N.V. boosted its stake in shares of Elevance Health, Inc. (NYSE:ELV - Free Report) by 157.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 205,796 shares of the company's stock after buying an additional 125,995 shares during the quarter. APG Asset Management N.V. owned 0.09% of Elevance Health worth $73,315,000 as of its most recent SEC filing.

Other institutional investors have also made changes to their positions in the company. Raelipskie Partnership purchased a new position in shares of Elevance Health during the 3rd quarter worth approximately $26,000. Flagship Wealth Advisors LLC purchased a new position in shares of Elevance Health during the fourth quarter worth $26,000. Dunhill Financial LLC grew its stake in shares of Elevance Health by 57.8% in the third quarter. Dunhill Financial LLC now owns 71 shares of the company's stock valued at $37,000 after buying an additional 26 shares in the last quarter. WealthTrak Capital Management LLC purchased a new stake in shares of Elevance Health in the 4th quarter valued at $29,000. Finally, Lee Danner & Bass Inc. acquired a new position in Elevance Health during the 4th quarter worth about $30,000. 89.24% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

ELV has been the subject of several research reports. Argus raised Elevance Health from a "hold" rating to a "buy" rating and set a $450.00 target price for the company in a research report on Monday, March 17th. Cantor Fitzgerald restated an "overweight" rating and issued a $485.00 price objective on shares of Elevance Health in a report on Friday, January 24th. Truist Financial raised their price target on shares of Elevance Health from $480.00 to $510.00 and gave the company a "buy" rating in a research report on Friday. Wells Fargo & Company lowered their price objective on Elevance Health from $483.00 to $478.00 and set an "overweight" rating for the company in a research report on Tuesday, January 28th. Finally, Guggenheim began coverage on shares of Elevance Health in a report on Wednesday. They set a "buy" rating and a $518.00 price target for the company. Two equities research analysts have rated the stock with a hold rating, sixteen have issued a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat, the company has an average rating of "Moderate Buy" and a consensus price target of $521.47.

Remove Ads

Insider Transactions at Elevance Health

In other Elevance Health news, CAO Ronald W. Penczek sold 443 shares of the business's stock in a transaction on Monday, March 10th. The shares were sold at an average price of $415.13, for a total value of $183,902.59. Following the transaction, the chief accounting officer now directly owns 1,847 shares of the company's stock, valued at approximately $766,745.11. The trade was a 19.34 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, EVP Charles Morgan Kendrick, Jr. sold 3,504 shares of the firm's stock in a transaction on Wednesday, March 5th. The stock was sold at an average price of $396.30, for a total transaction of $1,388,635.20. Following the completion of the sale, the executive vice president now owns 10,116 shares of the company's stock, valued at $4,008,970.80. This trade represents a 25.73 % decrease in their position. The disclosure for this sale can be found here. Insiders own 0.35% of the company's stock.

Elevance Health Stock Performance

NYSE:ELV traded up $3.43 during mid-day trading on Friday, reaching $439.80. 1,350,246 shares of the stock were exchanged, compared to its average volume of 1,441,797. The stock has a market capitalization of $99.56 billion, a P/E ratio of 17.17, a P/E/G ratio of 1.18 and a beta of 0.77. Elevance Health, Inc. has a 1 year low of $362.21 and a 1 year high of $567.26. The company has a 50 day simple moving average of $412.93 and a 200-day simple moving average of $413.32. The company has a quick ratio of 1.50, a current ratio of 1.45 and a debt-to-equity ratio of 0.71.

Elevance Health (NYSE:ELV - Get Free Report) last announced its earnings results on Thursday, January 23rd. The company reported $3.84 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $3.80 by $0.04. Elevance Health had a net margin of 3.38% and a return on equity of 18.28%. Analysts anticipate that Elevance Health, Inc. will post 33.96 earnings per share for the current fiscal year.

Elevance Health Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 25th. Stockholders of record on Monday, March 10th were issued a $1.71 dividend. This represents a $6.84 dividend on an annualized basis and a dividend yield of 1.56%. This is a boost from Elevance Health's previous quarterly dividend of $1.63. The ex-dividend date of this dividend was Monday, March 10th. Elevance Health's dividend payout ratio is presently 26.71%.

About Elevance Health

Elevance Health, Inc, together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.